← back to search

Pierre Sujobert

Laboratoire de Biométrie et Biologie Evolutive · FR
Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer, Lipids, and Metabolism, Ferroptosis and cancer prognosis, RNA modifications and cancer, and Lymphoma Diagnosis and Treatment.
h-index
24
citations
2,539
works
263
NIH funding
primary concept
Biology
email

Recent publications

American College of Rheumatology Guidance Statement for Diagnosis and Management of <scp>VEXAS</scp> Developed by the International <scp>VEXAS</scp> Working Group Expert Panel
Arthritis & Rheumatology 2025cited by 21position: middledoi
Epstein–Barr virus induces aberrant B cell migration and diapedesis via FAK-dependent chemotaxis pathways
Nature Communications 2025cited by 11position: middledoi
C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in <i>FLT3</i> -Mutant Leukemia
Cancer Discovery 2023cited by 87position: middledoi
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
Blood 2022cited by 201position: lastdoi
BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1
Blood 2022cited by 11position: lastdoi
Therapeutic options in VEXAS syndrome: insights from a retrospective series
Blood 2021cited by 276position: lastdoi
VEXAS syndrome in a woman
Lara D. Veeken 2021cited by 104position: middledoi
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells
Clinical Nuclear Medicine 2021cited by 81position: middledoi
Real‐life targeted next‐generation sequencing for lymphoma diagnosis over 1 year from the French Lymphoma Network
British Journal of Haematology 2021cited by 15position: middledoi
Commercial <scp>anti‐CD19 CAR</scp> T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center
American Journal of Hematology 2020cited by 133position: middledoi
The Need for a Consensus Next‐generation Sequencing Panel for Mature Lymphoid Malignancies
HemaSphere 2019cited by 36position: firstdoi
Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma
Blood 2018cited by 178position: middledoi
Treatment with Hypomethylating Agent 5-Azacytidine Induces Sustained Response in Angioimmunoblastic T Cell Lymphomas
Blood 2016cited by 31position: middledoi
Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups
Histopathology 2013cited by 34position: middledoi
CCND2 rearrangements are the most frequent genetic events in cyclin D1− mantle cell lymphoma
Blood 2012cited by 208position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Philippe Gaulard · Pitié-Salpêtrière Hospital4 papers (2012–2019)Gilles Salles · Universidade Federal do Estado do Rio de Janeiro3 papers (2019–2022)Thomas Barba · Imperial College London3 papers (2021–2022)Clémentine Sarkozy · Laboratoire d'imagerie translationnelle en oncologie3 papers (2016–2019)Yvan Jamilloux · Research on healthcare performance3 papers (2021–2022)Estelle Bourbon · Assistance Publique – Hôpitaux de Paris3 papers (2021–2021)Cécile‐Audrey Durel · Hospices Civils de Lyon2 papers (2021–2021)Alexandra Traverse‐Glehen · Université Claude Bernard Lyon 12 papers (2021–2022)Maël Heiblig · Centre de Recherche en Cancérologie de Lyon2 papers (2021–2022)Jehan Dupuis · Université Claude Bernard Lyon 12 papers (2016–2018) · 2 papers (2016–2018)Susanne Delécluse · German Cancer Research Center2 papers (2022–2025)Corinne Haïoun · Assistance Publique – Hôpitaux de Paris2 papers (2016–2018)Catherine Thiéblemont · Inserm2 papers (2019–2021)Henri‐Jacques Delecluse · German Cancer Research Center2 papers (2022–2025)François Lemonnier · Laboratoire de Génétique Cellulaire2 papers (2016–2018)Fiorenza Barraco · Centre Hospitalier Universitaire de Toulouse2 papers (2021–2022)Emmanuel Bachy · Université Claude Bernard Lyon 12 papers (2021–2022)Richard Delarue · Hôpital Necker-Enfants Malades2 papers (2016–2018) · 2 papers (2016–2018)